治疗儿童急性支气管炎和喘息发作的阿齐思罗米 - - 一项系统性综述与元分析
Rosa-Maria Ukkonen1, Marjo Renko1,2, Ilari Kuitunen3,4
1Institute of Clinical Medicine and Department of Pediatrics, University of Eastern Finland, Kuopio, Finland.
Pediatric research
|December 8, 2023
概括
阿齐思罗米可能会缩短急性支气管炎的幼儿住院的时间. 然而,这种抗生素并不能防止喘息的复发,也不能减少重症监护室的需要.
科学领域:
- 儿科 儿科 儿科
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性支气管炎和喘息在两岁以下的儿童中很常见.
- 目前针对这些疾病的治疗指南各不相同.
研究的目的:
- 系统地审查和元分析阿齐思罗米在治疗幼儿急性支气管炎和喘息时的疗效.
- 评估阿齐思罗米对住院时间,ICU入院和喘息复发的影响.
主要方法:
- 搜索了PubMed,Scopus和科学网络的随机对照试验.
- 包括在2岁以下的儿童中比较阿齐思罗米辛与安慰剂的研究.
- 使用随机效应模型分析了包括喘息发作进展和复发在内的结果.
主要成果:
- 包括来自1604份选摘要的7项研究;偏差风险不同.
- 阿齐思罗米显示了中等质量的证据,可将住院时间减少0.27天.
- 低质量的证据表明,ICU治疗需求或喘复发没有显著减少.
结论:
- 阿齐思罗米可能会减少急性支气管炎和喘息的幼儿住院时间.
- 有证据表明,阿齐思罗米不能防止喘息的复发或减少ICU入院.
- 需要使用更大的样本大小进行进一步的研究,以确认临床效用.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
450
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
450
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
293
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
293
Antiasthma Drugs: β2-Adrenoceptor Agonists
271
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
271
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305


